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PRELIMINARY AND SHORT REPORTS
DIODOQUIN AS A TOPICAL THERAPEUTIC AGENT IN
CUTANEOUS DISEASE*
WILLIAM LEIFER, M.D., AND KARL STEINER, M.D.
Diodoquin is therapeutically effective in amebiasis and other protozoal intestinal infec-
tions by oral administration, and in trichomonas vaginitis by topical application. Sulz-
berger and Kanof (1) found 5 per cent Diodoquin in talc an effective prophylactic and thera-
peutic agent against fungous infections of the feet, but less effective than undecylenic
powder. It occurred to us that Diodoquin might prove as valuable as some other hydroxy-
quinoline compounds (2) in the treatment of certain cutaneous diseases.
Diodoquin (5, 7-diiodo-8-hydroxyquinoline) is a fine, pale yellow powder that contains
63.9 per cent of iodine. It is insoluble in water, dilute acids, and alkalis, and is readily in-
corporated in ointments. Concentrations of 3, 5, and 10 per cent in petrolatum, hydrophilic
TABLE 1
Results of treatment with diodoquin ointment
DIAGNOSIS
RESPONSE TO TREAREENT
Cured Improved Unimproved
Sycosis vulgaris
Ecthyma
Infectious eczematoid dermatitis
Infected atopic dermatitis
Tinea cruris
Tinea corporis
Tinea pedis
Seborrheic dermatitis
Rosacea
7
1
3
5
3
1
2
3
2
6
1
2
0
3
0
1
0
2
1
0
1
4
0
0
0
2
0
0
0
0
1
0
1
1
1
0
Total 27 15 8 4
base (U.S.P. XIII), and aquaphor were prepared. Actually the 3 and 5 per cent concentra-
tions in hydrophilic base or aquaphor were used in the cases reported here.
This preliminary report gives the results obtained in 27 male and female patients. The
accompanying table classifies the cases according to diagnosis and therapeutic response.
The pyodermas responded excellently, in most instances clearing completely. Inflamma-
tory, probably secondarily infected, eruptions of the body folds were notably responsive.
Thus, three cases of inflamed tinea cruris were clinically cured, and the oozing fissures of
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atopic dermatitis usually healed quickly, with benefit to the underlying disease. There
was, as a rule, considerable improvement or complete disappearance of the eruptions of
seborrheic dermatitis and rosacea. Tinea corporis did not respond, and one case of tinea
pedis was cured and a second case unimproved.
There was no occurrence of sensitization in this group of 27 patients. Furthermore, the
ointment was well tolerated by inflamed surfaces (as in infectious eczematoid dermatitis,
inflamed tinea cruris, and inflamed seborrheic dermatitis) with comfort to the patient and
improvement of the disease.
While this preliminary report is based on a small experience our results continue to be
so encouraging that we hope to stimulate others to carry out broader and deeper studies.
Pyogenic and fungous infections of the skin are very common and there is room for addi-
tional therapeutically effective, well-tolerated agents of low sensitizing capacity. More-
over, sensitization to the quinolines does not have the clinical importance of sensitization
to penicillin or sulfonamides, which may interfere with subsequent administration of these
vital drugs. We feel as Tate (3) does about the quinoline derivatives that "their employ-
ment in dermatology merits much further study."
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